Application of magnetic resonance imaging to diagnosis of fatty liver disease

World Chinese Journal of Digestology

Volumn 15, Issue 24, 2007, Pages 2626-2630

  Tian, Yan ^a,b   Fan, Zhu Ping ^a,b   Gu, Hai Yan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Institute of Digestive Disease   (China)

Author keywords

Magnetic resonance imaging; Non alcoholic fatty liver disease

Indexed keywords

CLINICAL ASSESSMENT; DIAGNOSTIC IMAGING; FATTY LIVER; HUMAN; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

EID: 36849021537     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Hamer OW, Aguirre DA, Casola G, Lavine JE, Woenckhaus M, Sirlin CB. Fatty liver: imaging patterns and pitfalls. Radiographics 2006; 26: 1637-1653
2. Choudhury J, Sanyal AJ. Clinical aspects of fatty liver disease. Semin Liver Dis 2004; 24: 349-362
3. Ramesh S, Sanyal AJ. Evaluation and management of non-alcoholic steatohepatitis. J Hepatol 2005; 42 Suppl: S2-12
4. Merriman RB, Ferrell LD, Patti MG, Weston SR, Pabst MS, Aouizerat BE, Bass NM. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 2006; 44: 874-880
5. Semelka RC, Martin DR, Balci NC. Magnetic resonance imaging of the liver: how I do it. J Gastroenterol Hepatol 2006; 21: 632-637
6. Schick F. Whole-body MRI at high field: technical limits and clinical potential. Eur Radiol 2005; 15: 946-959
7. Prasad SR, Wang H, Rosas H, Menias CO, Narra VR, Middleton WD, Heiken JP. Fat-containing lesions of the liver: radiologic-pathologic correlation. Radiographics 2005; 25: 321-331
8. Merkle EM, Nelson RC. Dual gradient-echo in-phase and opposed-phase hepatic MR imaging: a useful tool for evaluating more than fatty infiltration or fatty sparing. Radiographics 2006; 26: 1409-1418
9. Martin DR, Semelka RC. Magnetic resonance imaging of the liver: review of techniques and approach to common diseases. Semin Ultrasound CT MR 2005; 26: 116-131
10. Qayyum A, Goh JS, Kakar S, Yeh BM, Merriman RB, Coakley FV. Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques-initial experience. Radiology 2005; 237: 507-511
11. Hussain HK, Chenevert TL, Londy FJ, Gulani V, Swanson SD, McKenna BJ, Appelman HD, Adusumilli S, Greenson JK, Conjeevaram HS. Hepatic fat fraction: MR imaging for quantitative measurement and display-early experience. Radiology 2005; 237: 1048-1055
12. Rinella ME, McCarthy R, Thakrar K, Finn JP, Rao SM, Koffron AJ, Abecassis M, Blei AT. Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: Implications for living liver donation. Liver Transpl 2003; 9: 851-856
13. Fishbein MH, Mogren C, Gleason T, Stevens WR. Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2006; 42: 83-88
14. Tanoli T, Yue P, Yablonskiy D, Schonfeld G. Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity. J Lipid Res 2004; 45: 941-947
15. Thomas EL, Hamilton G, Patel N, O'Dwyer R, Dore CJ, Goldin RD, Bell JD, Taylor-Robinson SD. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 2005; 54: 122-127
16. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288: E462-468
17. Cox IJ, Sharif A, Cobbold JF, Thomas HC, Taylor-Robinson SD. Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease. World J Gastroenterol 2006; 12: 4773-4783
18. Lim AK, Patel N, Hamilton G, Hajnal JV, Goldin RD, Taylor-Robinson SD. The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C. Hepatology 2003; 37: 788-794
19. Khan SA, Cox IJ, Hamilton G, Thomas HC, Taylor-Robinson SD. In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications. Liver Int 2005; 25: 273-281
20. Corbin IR, Buist R, Peeling J, Zhang M, Uhanova J, Minuk GY. Hepatic 31P MRS in rat models of chronic liver disease: assessing the extent and progression of disease. Gut 2003; 52: 1046-1053
21. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699
22. Cortez-Pinto H, Chatham J, Chacko VP, Arnold C, Rashid A, Diehl AM. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA 1999; 282: 1659-1664
23. van Wassenaer-van Hall HN, van der Grond J, van Hattum J, Kooijman C, Hoogenraad TU, Mali WP. 31P magnetic resonance spectroscopy of the liver: correlation with standardized serum, clinical, and histological changes in diffuse liver disease. Hepatology 1995; 21: 443-449
24. Solga SF, Horska A, Clark JM, Diehl AM. Hepatic 31P magnetic resonance spectroscopy: a hepatologist's user guide. Liver Int 2005; 25: 490-500
25. Bellentani S, Bedogni G, Miglioli L, Tiribelli C. The epidemiology of fatty liver. Eur J Gastroenterol Hepatol 2004; 16: 1087-1093
26. Talwalkar JA. Shall we bury the sword? Imaging of hepatic fibrosis. Gastroenterology 2006; 131: 1669-1671
27. Lorenzen J, Sinkus R, Adam G. Elastography: Quantitative imaging modality of the elastic tissue properties. Rofo 2003; 175: 623-630
28. Suga M, Matsuda T, Minato K, Oshiro O, Chihara K, Okamoto J, Takizawa O, Komori M, Takahashi T. Measurement of in vivo local shear modulus using MR elastography multiple-phase patchwork offsets. IEEE Trans Biomed Eng 2003; 50: 908-915
29. Manduca A, Oliphant TE, Dresner MA, Mahowald JL, Kruse SA, Amromin E, Felmlee JP, Greenleaf JF, Ehman RL. Magnetic resonance elastography: non-invasive mapping of tissue elasticity. Med Image Anal 2001; 5: 237-254
30. Bieri O, Maderwald S, Ladd ME, Scheffler K. Balanced alternating steady-state elastography. Magn Reson Med 2006; 55: 233-241
31. Muthupillai R, Lomas DJ, Rossman PJ, Greenleaf JF, Manduca A, Ehman RL. Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science 1995; 269: 1854-1857
32. Hamhaber U, Grieshaber FA, Nagel JH, Klose U. Comparison of quantitative shear wave MR-elastography with mechanical compression tests. Magn Reson Med 2003; 49: 71-77
33. Othman SF, Xu H, Royston TJ, Magin RL. Microscopic magnetic resonance elastography (microMRE). Magn Reson Med 2005; 54: 605-615
34. Rouviere O, Yin M, Dresner MA, Rossman PJ, Burgart LJ, Fidler JL, Ehman RL. MR elastography of the liver: preliminary results. Radiology 2006; 240: 440-448
35. Huwart L, Peeters F, Sinkus R, Annet L, Salameh N, ter Beek LC, Horsmans Y, Van Beers BE. Liver fibrosis: non-invasive assessment with MR elastography. NMR Biomed 2006; 19: 173-179
36. Bhakoo KK, Bell JD, Cox IJ, Taylor-Robinson SD. The application of magnetic resonance imaging and spectroscopy to gene therapy. Methods Enzymol 2004; 386: 303-313
37. Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin CB. Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology 2006; 239: 425-437